Risankizumab outperforms ustekinumab in treating moderate-to-severe Crohn’s disease

  • Post author:
  • Post category:uncategorized

Researchers compare the therapeutic efficacy of risakizumab and ustekinumab for the treatment of moderate-to-severe Crohn’s disease.